您的位置: 首页 > 农业专利 > 详情页

Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same
专利权人:
Aki Iwai;Yangmin Ning;Heather Balsiger;Johanny Tonos de Leon;Leonard M. Neckers;Marc B. Cox;Yeong Sang Kim;Jane B. Neckers
发明人:
Leonard M. Neckers,Marc B. Cox,Jane B. Neckers,Yeong Sang Kim,Aki Iwai,Yangmin Ning,Johanny Tonos de Leon,Heather Balsiger
申请号:
US13395976
公开号:
US08859207B2
申请日:
2010.09.14
申请国别(地区):
US
年份:
2014
代理人:
摘要:
Pharmaceutical compositions that bind to a predicted FK506 Binding Protein 52 (FKBP52) interaction surface on the androgen receptor hormone binding domain, otherwise known as FKBP52 Targeting Agents (FTAs) are provided. These compositions of the present invention are found to specifically recognize the FKBP52 regulatory surface on the androgen receptor and inhibit FKBP52 from functionally interacting with the androgen receptor. Compositions comprising the pharmaceutical composition, as well as methods of use, treatment and screening are also provided.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充